# OnCo record paper-dunleavy-da-epoch-r-pmbcl-nejm-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-dunleavy-da-epoch-r-pmbcl-nejm-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-dunleavy-da-epoch-r-pmbcl-nejm-2013" ;
  schema:name "Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma"@en ;
  schema:description "Infusional dose-adjusted EPOCH with rituximab cured almost every patient with primary mediastinal B-cell lymphoma without any radiotherapy, sparing young patients the heart and breast cancer risks of chest irradiation."@en ;
  schema:url <https://onco.cc/key-papers/paper-dunleavy-da-epoch-r-pmbcl-nejm-2013/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1214561>, <https://pubmed.ncbi.nlm.nih.gov/23574119/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1214561> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Dunleavy K, Pittaluga S, Maeda LS, et al." ;
  onco:cancers <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/> ;
  onco:journals <https://onco.cc/journals/nejm/> .